Patents by Inventor Jaspal Singh

Jaspal Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7754433
    Abstract: Methods are disclosed for determining the relative binding affinities of molecules for their binding partner. One type of molecule is an antibody, which has an antigen binding partner. Antibodies are tested for binding against limited dilutions of antigen. Antibodies that bind to the most dilute antigen concentrations are determined to have a higher relative binding affinity for the antigen than antibodies that only bind to more concentrated antigen preparations.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: July 13, 2010
    Assignee: Amgen Fremont Inc.
    Inventors: John Babcook, Xiao-Chi Jia, Jaspal Singh Kang, Li Zhang
  • Publication number: 20100136246
    Abstract: This invention relates to a method, and products thereof, for producing amine and/or thiol functionalised surfaces using plasma deposition and the subsequent derivatization of said functionalised surfaces using biomolecules.
    Type: Application
    Filed: October 24, 2007
    Publication date: June 3, 2010
    Inventors: JasPal Singh Badyal, Lee Harris, Wayne Schofield
  • Publication number: 20090324601
    Abstract: Targeted binding agents directed to the antigen PDGFR-alpha and uses of such agents are disclosed herein. More specifically the invention relates to fully human monoclonal antibodies directed to the antigen PDGFR-alpha and uses of these antibodies. Aspects of the invention also relate to hybridomas or other cell lines expressing such antibodies. The described targeted binding agents and antibodies are useful as diagnostics and for the treatment of diseases associated with the activity and/or overexpression of PDGFR-alpha.
    Type: Application
    Filed: August 2, 2007
    Publication date: December 31, 2009
    Applicant: AstraZeneca AB
    Inventors: David Charles Blakey, Susan Ann Cartlidge, Ian Foltz, Jaspal Singh Kang, Laura Taylor, Gadi Gazit-Bornstein, Naomi Laing
  • Publication number: 20090305026
    Abstract: Nanoporous sol-gel derived monoliths and methods for making nanoporous sol-gel derived monoliths are provided. The methods enable fine control over pore size and pore size distribution, e.g., so that pore sizes can be predetermined and precisely tuned over a range from 0.3 nm to about 30 nm, or over a range from about 0.3 nm to about 10 nm. The monoliths may be derived from any suitable sol-gel, but in some instances they are derived from silica sol-gels. The sol-gel derived monoliths with finely tunable pore sizes and narrow pore size distributions may be used for a variety of applications, e.g., as substrates or templates for high surface area electrodes, as substrates for high surface area sensor, or as a component in a filtration apparatus.
    Type: Application
    Filed: June 10, 2009
    Publication date: December 10, 2009
    Applicant: Nanotune Technologies Corp.
    Inventors: Shiho Wang, Jaspal Singh, Vinod M.P. Nair
  • Publication number: 20090258392
    Abstract: Compositions and methods are disclosed for generating immunoglobulin structural diversity in vitro, and in particular, for reducing biases in V region and J segment gene utilization, and for generating immunoglobulin V-D-J recombination events in a manner that does not require D-J recombination to precede V-DJ recombination. Selection of advantageous combinations of immunoglobulin gene elements, including introduction of artificial diversity (D) segment genes and optimization of recombination signal sequence (RSS) efficiency, are disclosed.
    Type: Application
    Filed: April 14, 2009
    Publication date: October 15, 2009
    Inventors: Michael Gallo, Jaspal Singh Kang, Craig Robin Pigott
  • Patent number: 7572444
    Abstract: Binding proteins, such as fully human monoclonal antibodies and fragments thereof, directed to the antigen Matriptase and uses of such binding proteins are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising heavy and light chain immunoglobulin molecules capable of binding to Matriptase are also disclosed. The invention also discloses cell lines expressing such immunoglobulin molecules and monoclonal antibodies to Matriptase. The antibodies can be used to detect, prevent, and treat diseases such as cancer.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: August 11, 2009
    Assignees: Amgen Fremont Inc., Dendreon Corporation
    Inventors: Ian Foltz, Chadwick King, Peter Koon Bong Ling, Jaspal Singh Kang, Kathy Manchulenko, Francine Chen, Caroline Darne Scatena, Bruce A. Keyt, Edwin Madison, Wayne R. Godfrey, Stanislaw K. Morkowski, Jennifer H. Richardson
  • Patent number: 6843589
    Abstract: A low profile lighting system for military or other heavy equipment vehicles that includes a high intensity discharge (HID) headlight, and light emitting diode (LED) turn signals and running light. A microprocessor controller is included to interface to the vehicle lighting control system. An electromechanical actuator lifts and holds the light unit in place. The light unit is mounted on a hidden hinge in an armored and signature managed housing. The unique hinge design allows for electromechanical actuation of the lights from a micro-controller. The special hinge enables the external surfaces of the vehicle to be generally planar, and thereby ready to accept further signature management treatments.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: January 18, 2005
    Assignee: United Defense LP
    Inventors: Jaspal Singh Dhillon, Valent Horvatich, James Robert Turner, Marco Albert Middione
  • Publication number: 20030186327
    Abstract: Methods are disclosed for determining the relative binding affinities of molecules for their binding partner. One type of molecule is an antibody, which has an antigen binding partner. Antibodies are tested for binding against limited dilutions of antigen. Antibodies that bind to the most dilute antigen concentrations are determined to have a higher relative binding affinity for the antigen than antibodies that only bind to more concentrated antigen preparations.
    Type: Application
    Filed: December 2, 2002
    Publication date: October 2, 2003
    Inventors: John Babcook, Xiao-Chi Jia, Jaspal Singh Kang, Li Zhang
  • Publication number: 20030175760
    Abstract: Methods to screen antibodies against an antigen, categorize them according to the epitope they recognize, and rank them according to their binding affinities, thereby providing a method to rapidly and efficiently identify antibodies having potential usefulness in therapeutic products are described. Also described are methods of evaluating antibodies to determine their potential usefulness in therapeutic products.
    Type: Application
    Filed: December 2, 2002
    Publication date: September 18, 2003
    Inventors: Wynn L. Walker, John S. Babcook, C. Geoffrey Davis, Larry L. Green, Jaspal Singh Kang, Xiao-Chi Jia, Michael L. Gallo, Keith Joho
  • Publication number: 20030157730
    Abstract: Methods for categorizing antibodies based on their epitope binding characteristics are described. Methods and systems for determining the epitope recognition properties of different antibodies are provided. Also provided are data analysis processes for clustering antibodies on the basis of their epitope recognition properties and for identifying antibodies having distinct epitope binding characteristics.
    Type: Application
    Filed: December 2, 2002
    Publication date: August 21, 2003
    Inventors: Wynn L. Walker, Michael L. Gallo, Xiao-Chi Jia, Keith Joho, Jaspal Singh Kang
  • Patent number: 5454058
    Abstract: An optical component fabricated from a semi-conductor wafer in which the epilayers are in the InCaAsP system comprises a pair of ridge waveguides. The ridge waveguides are proximate and parallel to each other in a first region, and diverge from each other in a second region. Each waveguide has a continuous electric contact over its upper surface to provide a first light amplification zone through or beneath at least a portion of both first and second light guiding paths and a second light amplification zone through or beneath at least a portion of both the first and a third light guiding path. The component can be used as a low loss 1.times.2 switch, or as a low loss 2.times.1 combiner.
    Type: Grant
    Filed: November 24, 1992
    Date of Patent: September 26, 1995
    Assignee: BT&D Technologies, Ltd.
    Inventors: David Mace, Michael J. Adams, Michael A. Fisher, Jaspal Singh, Ian D. Henning